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Objective  To investigate the additive effect of sono-guided subacromial bursa injection of hyaluronate with 
steroid in patients with peri-articular shoulder disorders.
Method  This prospective randomized controlled trial involved 26 patients who had shoulder pain. Group A, 
consisting of 13 patients, was treated with a sono-guided subacromial bursa injection containing a mixture of 0.5% 
lidocaine (5 ml) and triamcinolone 40 mg (1 ml), followed by injection with  sodium hyaluronate (2 ml) once a 
week for 3 weeks. Th   e other 13 patients (Group B) were treated with a sono-guided subacromial bursa injection 
containing a mixture of 0.5% lidocaine (5 ml) and triamcinolone 40 mg (1 ml) once a week for 3 weeks. Th  e  eff  ects 
were assessed using a visual analogue scale (VAS) of shoulder pain, active range of motion (AROM), shoulder 
function assessment scale (SFA), shoulder disability questionnaire (SDQ) at study entry and every week from fi  rst 
injection until 4 weeks after the 1
st injection (= 2 weeks after 3
rd injection). 
Results  (1) Demographic features and all parameters measured before injection did not show a significant 
diff  erence between the 2 groups. (2) Statistically signifi  cant improvements were shown in VAS, SFA, SDQ during 
the 1
st, 2
nd, and 4
th week after the fi  rst injection in both groups (p<0.05). (3) SFA showed signifi  cant improvement at 
1 week after injection only in group A (p<0.05). (4) AROM of internal rotation showed signifi  cant improvement at   
week 4 after the 1
st injection only in group A (p<0.05).
Conclusion  Subacromial bursa injection of hyaluronate with steroid in patients with peri-articular shoulder 
disorders has additive eff  ects on functional improvement of the aff  ected shoulder, including the AROM of internal 
rotation.
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INTRODUCTION
  Subacromial bursa injection of steroid in a peri-articular 
shoulder disorder patient is one of the common treatment 
methods clinically used for pain relief and improvement 
of function.
1-3 Recently, hyaluronate has been reported to 
be an eff  ective and safe method for treating peri-articular 
shoulder disorder and adhesive capsulitis of shoulder.
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Chou et al.
7 suggested hyaluronate as a substitute for 
steroid, because significant improvement of symptoms 
was shown in an initial randomized,  double-blinded,   
placebo-controlled trial in rotator cuff disease patients 
without full-thickness tear where only hyaluronate was 
injected. Kim et al.
8 suggested that subacromial bursa 
injection of hyaluronate is useful method as a substitute 
for injection of steroid in adhesive capsulitis patients who 
cannot be easily treated with steroid, such as diabetes 
patients; however, it was not more eff  ective than steroid. 
Studies have been reported where subacromial bursa 
injection of steroid or hyaluronate was done exclusively 
to compare their eff  ectiveness in peri-articular shoulder 
disorder patients or to investigate effectiveness by 
injecting both of them in adhesive capsulitis patients. 
However, no study has been conducted to investigate 
the eff  ectiveness of subacromial bursa injection of both 
agents in peri-articular shoulder disorder patients.
  This study was conducted to determine whether 
hyaluronate would have additive effectiveness in peri-
articular shoulder disorder patients in which a combined 
formulation of steroid and hyaluronate was injected 
in the subacromial bursa  for 3 times, and results were 
compared with those from  injection of steroid alone.
 
MATERIALS AND METHODS
Subjects 
  Study participants were inpatients who came to 
rehabilitative medicine with a chief complaint of 
shoulder pain between April 2010 and August 2010. 
Subjects eligible for this study had, (1) clinically painful 
arc and Hawkin's sign or positive Neer's impingement 
sign, (2) had a partial tear or full thickness tear of a 
rotator cuff  , or subacromial bursitis among peri-articular 
soft tissue disorders of the shoulder in a sonogram. 
Criteria for exclusion were: (1) Adhesive capsulitis 
of the shoulder (diagnosed when the x-ray view was 
normal, and active and passive elevation of the arm 
was <100 degree, and passive external rotation of the 
glenohumeral joint measured with the elbow bent 90 
degree with an examiner holding the subject’s wrist was 
50% reduced compared to the tendon side),
9 (2) History 
of previous shoulder surgery, (3) History of steroid or 
hyaluronate injection in the shoulder for the same cause, 
(4) Hemiplegic shoulder pain syndrome, (5) Fracture  was 
suspected in simple x-ray image.  Patients who met the 
criteria were chosen and categorized as group A or group 
B.  Physical examinations, shoulder pain, and functional 
assessments were conducted, followed by sono-guided 
subacromial bursa injection. 
Procedure and intervention   
  Confi  rmation of lesion was done using a sonogram after 
physical examination and assessment of shoulder pain 
and function., Patients were asked to rotate their arm 
internally, extend excessively, and attach their lower 
arm to the back of himself/herself in a sitting posture. 
Th   en, the injection site was sterilized and a sono-guided 
subacromial bursa injection was done. Injections were 
done in every patient in both groups at an interval of 1 
injection per week for 3 weeks. Group A patients were 
treated with a mixture of 40 mg triamcinolone acetonide 
(Dong Kwang Parm., Seoul, Korea) (1 ml), 0.5% lidocaine 
Fig. 1. Figure shows ultrasound 
guided subacromial/subdeltoid 
bursa injection. The needle tip 
is positioned at subacromial/
subdeltoid bursa (A). Subacromial/
subdeltoid bursa is dilatated due to 
the injection materials (B). Seung Deuk Byun, et al.
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(5 ml), and hyaluronate Hyruan Plus
® ( LG Chemical, 
Seoul, Korea) at the same site. Group B patients were 
treated with a mixture of 40 mg triamcinolone acetonide   
(1 ml) and 0.5% lidocaine (5 ml) (Fig. 1). Administration 
of any pain reliever or anti-inflammatory drug was 
ceased starting 1 week prior to injection, and patients 
were instructed to exercise for stabilization and stretch 
the shoulder muscle after injection, Also, continuous 
education concerning exercise was recommended during 
weekly followup appointments. Additional physical 
therapy or drug treatment was not used.
Assessment of eﬀ  ectiveness of injection
  Patient assessments were conducted prior to the first 
injection, 1 week after the first injection (before 2
nd 
injection), 1 week after 2
nd injection (before 3
rd injection), 
and 2 weeks after the final 3
rd injection. Assessments 
were carried out by the same physiatrist who had been 
in charge of assessment before injection. First, VAS was 
measured (scale of 0 to 10) by assessing the mean value 
for pain during the previous 24 hours. Second, active 
movement range of the shoulder joint was measured, 
and in doing so, movement of the scapula was included. 
Flexion and abduction of the shoulder joint were 
measured with the main joint being stretched in a sitting 
posture and upper limb movement range was measured 
in sagittal and coronal surfaces, respectively. External 
and internal rotation were defined as their movement 
range with the shoulder joint being supinated 90 degree 
in a sitting posture.
  Lastly, a shoulder function assessment scale (SFA) and 
shoulder disability questionnaire (SDQ) were used to 
assess shoulder function of the patient. SFA is an assess-
ment tool that is statistically reliable and is composed 
of 9 items for measuring degree of pain during rest and 
movement (minimum 0 to maximum 30), functions in 
daily life, range of motion of shoulder, from a minimum 
of 0 (shoulder function is the worst) to a maximum of 
70 (shoulder function is the best) and scores can range 
from 0 to 100 by summation.
10 The SDQ is a proven 
assessment tool  used to measure the degree of disability 
that a patient feels and is composed of 22 self reported 
questionnaires and it ranges from a minimum score of 
0 (no disability) to a maximum score of 22 (maximum 
disability).
11
Statistical analysis
  Age, sex, and site of occurrence were compared by 
Chi-square analysis and an independent t-test, and the 
Wilcoxon signed rank test was used to compare values 
for pre-injection, 1 week after 1
st injection, 1 week after 
2
nd injection, and 2 weeks after the 3
rd injection of both 
steroid plus hyaluronate injection groups and the steroid 
only injection group, and also to compare values of the 2 
groups at each point. SPSS 12.0 was used as the statistical 
program and statistical signifi  cance was at p-value<0.05.
RESULTS
Characteristics of subjects
  A total of 26 patients were enrolled in group A and 
their mean age was 55.5±12.1. The mean age of the 13 
subjects in group B was 55.4±10.0. In both groups; 3 were 
Table 1. General Characteristics of Subjects
Group A Group B Total
Number of
 subject
13 13 26
Sex (male/
 female)
3/10 3/10 6/20
Age (years) 55.5±12.1 55.4±10.0 55.4±10.9
  Shoulder
   aff  ected, n (%)
9 (69.2%) 10 (76.9%) 19 (73.1%)
  Dominant 4 (30.8%)   3 (33.1%)   7 (36.9%)
  Non-dominant
    VAS  7.7±1.7   6.9±1.9 7.3±1.8
    SFA   67.4±18.6 67.2±7.7 67.3±14.0
    SDQ 10.5±6.4    8.9±4.5 9.7±5.5
Range of Motion
  Flexion 170.0±17.3 166.2±15.0 168.1±16.0
  Abduction 151.5±25.4 159.2±19.8 155.4±22.7
  IR    56.9±23.6    83.9±17.1    61.2±60.7
  ER    73.1±25.0    83.9±11.2    75.4±20.6
Values are mean±standard deviation
Group A: patients injected with 0.5% lidocaine 5 ml+ 
triamcinolone 40 mg+high molecular weight sodium 
hyaluronate 2 ml, Group B: patients injected with 0.5% 
lidocaine+triamcinolone 40 mg, VAS: visual analogue 
scale, SFA: Shoulder function assess    ment scale, SDQ: 
Shoulder disability question  naire, IR: Internal rotation, 
ER: External rotationSubacromial Bursa Injection of Hyaluronate with Steroid in Peri-articular Shoulder Disorders
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male and 10 were female and there was no statistically 
signifi  cant diff  erence (p>0.05)(Table 1). Th   ere also was no 
statistically significant difference in assessment criteria 
which were measured before injection (p>0.05) (Table 
1). There was no significant difference in sonographic 
diagnosis that was done prior to injection in both groups 
(Table 2). 
Change of visual analogue scale (VAS) 
  There was significant improvement of VAS at 1 week 
after the 1
st injection in both groups compared with pre-
injection (p<0.05). Although there was a statistically 
significant improvement in group A at 1 week after the 
2
nd injection compared to 1 week after the 1
st injection 
(p<0.05), it was not statistically significant in group B 
(p>0.05). There also was a significant improvement at 
2 weeks after the 3
rd injection compared to 1 week after 
the 2
nd injection in group A (p<0.05) (Table 3). However, 
there were significant improvements in both groups 
when comparing results at 2 weeks after the 3
rd injection 
to those at pre-injection (p<0.05) (Fig. 2). Although there 
was a greater improvement in group A when comparing 
degrees of improvement at 2 weeks after the 3
rd injection 
and pre-injection in both groups, it was not statistically 
signifi  cant (p>0.05) (Table 4).
 
Change of SFA 
  For SFA, there was a statistically signifi  cant improvement 
only in group A when comparing results at 1 week after 
the 1
st injection to results at pre-injection (p<0.05), but 
there was no signifi  cant diff  erence (p>0.05) in group B. 
  There was a statistically significant improvement in 
group A only when comparing results at 1 week after the 
2
nd injection and 2 weeks after the 3
rd injection to prior 
Table 2. Ultrasonographic Diagnosis before Injection
Findings
 Group A
(n=13)
 Group B
(n=13)
RC partial-tear 5  4 
RC full-thickness tear 4  4 
SA-SD bursitis 4  5 
Values indicate number of cases
RC: Rotator cuff  , SA-SD: Subacro  mial-subdeltoid
Table 3. Summary of Treatment Eff  ects in Group A and B
Group Pre-injection
1 week after 
1
st injection
1 week after 
2
nd injection
2 weeks after 
3
rd injection
VAS A   7.7±1.7      4.7±2.2
†    2.8±1.2
‡       1.7±1.1*
,§
B   6.9±1.9      3.5±1.8
†  2.5±1.5      2.4±1.9*
SFA A   67.4±18.6      79.3±11.8
† 86.3±9.9
‡     91.0±8.0*
,§
B 67.2±7.7     80.9±10.5 86.0±8.2   86.0±8.3*
SDQ A 10.5±6.4       6.6±6.0
†     5.1±4.8
‡       3.5±3.8*
,§
B   8.9±4.5       4.9±3.8
†    3.5±2.8     3.1±2.6*
ROM (degree)
Flexion A 170.0±17.3      176.2±11.2
†    177.7±8.32 178.5±5.6*
B 166.2±15.0  175.4±8.8  178.5±3.8 177.6±6.0*
Abduction A 151.5±25.4     163.9±19.4
†      170.8±14.4
‡   174.6±10.5*
B 159.2±19.8   172.3±9.3
†  176.2±5.1 176.2±8.7*
Internal rotation A  56.9±23.6        70.4±23.3
†        76.2±20.6
‡      80.1±17.1*
B  62.3±17.9      65.4±14.5       66.2±15.6      69.2±17.1*
External rotation A  73.1±25.0       83.9±17.1
†       84.6±14.5    86.2±9.6*
B  77.7±15.9   83.85±11.2    89.2±2.8    89.2±2.8*
Values are mean±standard deviation
Group A: patients injected with 0.5% lidocaine 5 ml+triamcinolone 40 mg+high molecular weight sodium hyaluronate 
2 ml, Group B: patients injected with 0.5% lidocaine+triamcinolone 40 mg, VAS: Visual analogue scale, SFA: Shoulder 
function assessment scale, SDQ: Shoulder disability questionnaire
*p<0.05 pre-injection vs 2 weeks after 3
rd injection, 
†p<0.05 pre-injection vs 1 week after 1
st injection, 
‡p<0.05 1 week 
after 1
st injection vs 1 week after 2
nd injection, 
§p<0.05 1 week after 2
nd injection vs 2 week after 3
rd injectionSeung Deuk Byun, et al.
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results (p<0.05), but there were signifi  cant improvements 
in both groups when comparing results at 2 weeks after 
the 3
rd injection to those at pre-injection (p<0.05) (Table 3, 
Fig. 3).
  There was a greater improvement in group A when 
comparing degree of improvement at 2 weeks after the 
3
rd injection and pre-injection; however, it was not a 
statistically signifi  cant (p>0.05) (Table 4).
Change of SDQ 
  Th   ere were signifi  cant improvements of SDQ at 1 week 
after the 1
st injection compared to pre-injection in both 
groups (p<0.05). There was a statistically significant 
improvement in group A only when comparing results 
at 1 week after the 2
nd injection and 2 weeks after the 3
rd 
injection to prior results (p<0.05) (Table 3). However, 
Fig. 2. Figure shows the changes of visual analogue scale 
(VAS) after 3 consecutive injections. *p<0.05 pre-injection 
vs 2 weeks after 3
rd injection. 
†p<0.05 pre-injection vs 1 week 
after 1
st injection. 
‡p<0.05 1 week after 1
st injection vs 1 week 
after 2
nd injection. 
§p<0.05 1 week after 2
nd injection vs 2 weeks 
after 3
rd injection.
Table 4. Degree of Changes in Measurement Values of 
Group A and B 
Group A Group B
VAS 6.0±1.6    4.6±2.5
SFA 24.3±14.7  18.0±4.6
SDQ 7.0±4.1    4.3±2.6
Range of Motion
Flexion   8.5±12.8   11.5±11.4
Abduction 23.1±21.4   16.9±12.5
IR   23.5±18.0* 10.8±4.9
ER 12.3±19.2      9.2±13.2
Values are mean±standard deviation
Group A: Patients injected with 0.5% lidocaine 5 
ml+triamcinolone 40 mg+high molecular weight sodium 
hyaluronate 2 ml, Group B: Patients injected with 0.5% 
lidocaine + triamcinolone 40 mg, VAS: Visual analogue 
scale, SFA: Shoulder function assessment scale, SDQ: 
Shoulder disability question  naire, IR: Internal rotation, 
ER: External rotation
*p<0.05 steroid vs steroid plus hyaluronate
Fig. 3. Figure shows the changes of shoulder function 
assessment scale (SFA) after 3 consecutive injections. *p<0.05 
pre-injection vs 2 weeks after 3
rd injection. 
†p<0.05 pre-
injection vs 1 week after 1
st injection. 
‡p<0.05 1 week after 1
st 
injection vs 1 week after 2
nd injection. 
§p<0.05 1 week after 2
nd 
injection vs 2 week after 3
rd injection.
Fig. 4. Figure shows the changes of shoulder disability 
questionnaire (SDQ) after 3 consecutive injections. *p<0.05 
pre-injection vs 2 weeks after 3
rd injection. 
†p<0.05 pre-
injection vs 1 week after 1
st injection. 
‡p<0.05 1 week after 1
st 
injection vs 1 week after 2
nd injection. 
§p<0.05 1 week after 2
nd 
injection vs 2 weeks after 3
rd injection.Subacromial Bursa Injection of Hyaluronate with Steroid in Peri-articular Shoulder Disorders
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there were signifi  cant improvements in both groups when 
comparing the results at 2 weeks after the 3
rd injection to 
those of pre-injection (p<0.05) (Fig. 4).
  There was a greater improvement in group A when 
comparing the 2 groups’ degree of improvement at 2 
weeks after the 3
rd injection and pre-injection, but the 
difference was not a statistically significant (p>0.05) 
(Table 4).
Change of active range of motion 
  Although there was statistically signifi  cant improvement 
for active range of motion of abduction at 1week after 1
st 
injection in both groups compared to pre-injection, there 
were signifi  cant improvement for active range of motion 
of flexion, internal and external rotation at 1 week after 
1
st injection in group A only compared to pre-injection 
(p<0.05) (Table 3). There were statistically significant 
improvements for active range of motion of flexion, 
abduction, internal and external rotation at 2 weeks after 
the 3
rd injection in both groups compared to pre-injection 
(p<0.05) (Table 3, Fig. 5-8). When comparing degree of 
improvement in flexion of the shoulder joint, there was 
a greater diff  erence in group B, but it was not statistically 
significant (p>0.05) (Table 4). However, in cases of 
abduction of the shoulder joint and internal rotation 
and external rotation, there was a greater improvement 
in group A, and it was not statistically significant for 
abduction and external rotation, but it was statistically 
signifi  cant for internal rotation (p<0.05) (Table 4, Fig. 9).
DISCUSSION
  Subacromial bursa injection of steroid in shoulder 
disorders such as subacromial bursitis is often done 
repeatedly, but there is controversy concerning the 
Fig. 5. Figure shows the changes of AROM of shoulder fl  exion 
after 3 consecutive injections. *p<0.05 pre-injection vs 2 
weeks after 3
rd injection. 
†p<0.05 pre-injection vs 1 week after 
1
st injection. 
‡p<0.05 1 week after 1
st injection vs 1 week after 
2
nd injection. 
§p<0.05 1 week after 2
nd injection vs 2 weeks 
after 3
rd injection.
Fig. 6. Figure shows the changes of AROM of shoulder 
abduction after 3 consecutive injection. *p<0.05 pre-injection 
vs 2 weeks after 3
rd injection. 
†p<0.05 pre-injection vs 1 week 
after 1
st injection. 
‡p<0.05 1 week after 1
st injection vs 1 week 
after 2
nd injection. 
§p<0.05 1 week after 2
nd injection vs 2 weeks 
after 3
rd injection.
Fig. 7. Figure shows the changes of AROM of shoulder 
internal rotation after 3 consecutive injections. *p<0.05 pre-
injection vs 2 weeks after 3
rd injection. 
†p<0.05 pre-injection vs 
1 week after 1
st injection. 
‡p<0.05 1 week after 1
st injection vs 1 
week after 2
nd injection. 
§p<0.05 1  week after 2
nd injection vs 2 
weeks after 3
rd injection.Seung Deuk Byun, et al.
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appropriate number of injections, interval, and dose of 
steroid.
12-15 
  Concerning the dose of steroid, Yoon et al.
15 compared 
results at 1, 3, and 6 weeks after a 1
st injection of triam-
cinolone 10 mg and 40 mg respectively, and there was 
no difference in effectiveness depending on dose at 1 
and 3 weeks, but they reported that there was a greater 
significant improvement in pain, range of motion, and 
shoulder function of at 6 weeks after injection of 40 mg 
triamcinolone compared to 10 mg.
  Concerning the number of repetitions, Tillander et 
al.
13 reported that there were findings of fragmentation 
of collagen, necrosis, and local inflammation at 8 
weeks after repeated injection, although there was 
no histological change of rotator cuff after 3 repeated 
injections of triamcinolone when they investigated 
histological change of rotator cuff by injecting saline 
and triamcinolone 8 times in total, consisting of 3 time 
injections at an interval of 1 week and 5 time injections 
at an interval of 2 weeks. Also, Bhatia et al.
16 reported that 
subacromial bursa injection of steroid in patients with 
subacromial impingement syndrome was not the cause of 
damage to rotator cuff   because there was no statistically 
significant difference between 2 groups of 230 patients 
with clinical findings of subacromial impingement 
syndrome who were treated with triamcinolone >3 times 
and patients who were treated <3 times when comparing 
the 2 groups by determining whether there was of rotator 
cuff   damage using MRI. 
  In this study we injected 40 mg of triamcinolone with 
0.5% lidocaine (5 ml) 3 times at an interval of 1 week 
consecutively in the subacromial bursa of 26 patients 
with peri-articular shoulder disorder diagnosed with 
clinical fi  ndings of subacromial bursitis or damage of the 
rotator cuff by sonogram, and simultaneously injected 
hyaluronate in addition to steroid in the patients who 
were randomly chosen. 
  Hyaluronate is glycosaminoglycan, a main component 
of synovia, and it plays important roles in lubrication 
of joints, and preservation of cartilage tissue. Also, 
bursa injection of hyaluronate in osteoarthritis of the 
knee and shoulder is being suggested as one of the 
treatment methods that can substitute for using steroids 
for reducing join pain, having an anti-inflammatory 
eff  ect, increasing range of motion of the joint, inhibiting 
denaturalization of cartilage tissue, and normalizing 
abnormal articular fluid.
7,17-21 Hyaluronate is injected at 
intervals of 1 week and in general, its effects are shown 
after 2 weeks.
18,22
  In this study, as set by the clinical protocol, we moni-
tored results of the last 3
rd injection for 2 weeks, which is 
thought to be the time required for hyaluronate to show 
an additive effect, but we fully reflected the additive 
eff  ect because we monitored for longer than 4 weeks after 
the 1
st injection.
  There were statistically significant improvements in 
Fig. 8. Figure shows the changes of AROM of shoulder 
external rotation after 3 consecutive injections. *p<0.05 pre-
injection vs 2 weeks after 3
rd injection. 
†p<0.05 pre-injection vs 
1 week after 1
st injection. 
‡p<0.05 1 week after 1
st injection vs 1 
week after 2
nd injection. 
§p<0.05 1  week after 2
nd injection vs 2 
weeks after 3
rd injection.
Fig. 9. Degree of changes in measurement values (VAS, SFA, 
SDQ, AROM) of the 2 groups. *p<0.05 steroid vs steroid plus 
hyaluronate.Subacromial Bursa Injection of Hyaluronate with Steroid in Peri-articular Shoulder Disorders
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VAS, SFA, SDQ and full range of active range of motion of 
the shoulder in both groups 2 weeks after 3 consecutive 
injection. However, there was a greater improvement 
when injecting hyaluronate combined with steroid 
in all assessment criteria except for the flexion range. 
There was a statistically significant improvement 
especially in active internal rotation range in hyaluronate 
additive group, and this improvement is thought to be a 
meaningful result considering the fact that the symptoms 
were seen in internal rotation usually in peri-articular 
shoulder disorder.
  When comparing measurement values at each time 
interval, group B showed statistically significant 
improvement only in VAS, SDQ and abduction at 1 week 
after 1
st injection compared to pre-injection. However, 
Group A showed statistically significant improvement 
in VAS, SDQ, abduction, and SFA, which is a more 
functional assessment tool, and also forward flexion, 
internal rotation, and external rotation. These results 
indicate that one time injection of a combination of 
hyaluronate plus steroid could be an alternative of one 
time injection of steroid in patients who cannot be 
treated with repeated injections of steroid to achieve 
better functional improvement. 
  Kim et al.
23 reported that there was a better treatment 
effect in a steroid injection group than a hyaluronate 
injection group in terms of speed and degree of pain 
relief, although their results were similar for improvement 
in range of motion of joint in a comparative study on 
effectiveness of injection of hyaluronate and steroid in 
patients with adhesive casulitis. The reason treatment 
with hyaluronate was comparatively less effective was 
judged to be the result of hyalurontate’s initial failure rate 
being high in the injection group.
  We ruled out using a single injection of hyaluronate 
when deciding the method of study because we thought 
initial failure rate and patients’ dissatisfaction rate 
would be high because subacromial bursa injection of 
hyaluronate was less effective than injection of steroid 
only. We believe that studies on the effectiveness 
of subacromial bursa injection of steroid only and 
hyaluronate only as well as intra-articular shoulder 
injection will be necessary in the future.
  Kim et al.
9 reported on the effectiveness of combined 
therapy of hyaluronate and steroid in patients with 
adhesive capsulitis, but it was diff  erent from this study in 
subject and method of study because steroid was injected 
at the fi  rst week and hyaluronate only was injected in the 
articular capsule of the shoulder for 2 weeks at an interval 
of 1 week. 
  Also, Cho et al.
6 injected a combination containing 
Depo-Medrol to patients in a study and reported on 
the effectiveness of 5 time subacromial bursa injection 
of hyaluronate, but it was different from this study that 
excluded adhesive capsulitis patients.
  This study is thought to be meaningful because that 
we chose peri-articular shoulder disorder as the object 
of the study, chose subacromial bursa as an injection 
site (not intra-articular injection) and attempted to 
determine whether there was added effi   cacy by injecting 
a combination of steroid and hyaluronate. 
  However, the number of subjects in this study was not 
large, the duration of follow-up observation was short, 
and it is thought that additive studies including patients 
with a wider variety of disease are necessary. However, 
it is expected that the results of this study will assist in 
choosing medicine to be injected in bursa and deciding 
the number of injections in the future.
CONCLUSION
  This study was conducted to determine whether there 
was additive effectiveness of hyaluronate when being 
injected with a steroid by comparing the effectiveness 
of treatment in a group where steroid only was injected 
for 3 times at an interval of 1 week with a group where 
hyaluronate was injected with steroid in the subacromial 
bursa of patients with peri-articular shoulder disorder.
  Th   ere was a greater improvement at 2 weeks after the 3
rd 
injection when a combination of steroid and hyaluronate 
was injected as assessed by VAS, SFA, and SDQ, but the 
difference was not a statistically significant. Also, SFA 
improved with statistical significance only in the group 
where hyaluronate plus steroid was injected together at 
1 week after the 1
st injection, and there was a statistically 
significant difference in active internal rotation at 2 
weeks after the 3
rd injection, which showed a greater 
improvement. 
  Based on the results above, it is considered that there 
is an additive effectiveness in improving shoulder joint 
movement and function, including active internal 
rotation when hyaluronate are used adjunctively with 
steroid, although there are diff  erences depending on the 
number of injections.Seung Deuk Byun, et al.
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